Effects of a Presidential Candidate's Comments on HPV Vaccine by Zucker, Rachel A. et al.
Effects of a Presidential Candidate’s Comments on HPV Vaccine
Rachel A. Zucker, BA1, Paul L. Reiter, PhD2,3, Melissa K. Mayer, BA1, and Noel T. Brewer, 
PhD1,4
1UNC Gillings School of Global Public Health, Chapel Hill, NC
2Division of Cancer Prevention and Control, College of Medicine, The Ohio State University, 
Columbus, OH
3Comprehensive Cancer Center, The Ohio State University, Columbus, OH
4UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC
Abstract
Background—During and after the 2011 Republican presidential debate, a candidate questioned 
the safety of HPV vaccine. We sought to determine what effect these comments had on parents.
Methods—A national sample of 327 parents with adolescent sons ages 11–17 completed online 
surveys in fall 2010 (baseline, about a year before the debate) and 2011 (follow-up, about a month 
after the debate). We used regression models to examine the association of parents’ awareness of 
the candidate’s comments with HPV vaccine initiation among their sons, their willingness to get 
sons free HPV vaccine, and their beliefs about potential harms of HPV vaccine.
Results—Overall, 17% of parents reported hearing about the Republican presidential candidate’s 
comments about HPV vaccine. Parents who were aware of the comments had a larger increase 
between baseline and follow-up in the belief that HPV vaccine might cause short-term health 
problems (mean change=0.47) compared to parents who were not aware (mean change=0.07, 
p<0.001). Awareness was not associated with HPV vaccine initiation among parents’ adolescent 
sons, changes in parents’ willingness to get their sons free HPV vaccine, or other outcomes (all 
p>0.05).
Conclusions—Although the candidate’s comments may have increased some parents’ beliefs 
about the short-term harms of HPV vaccine, the comments had no impact on other beliefs, 
willingness to vaccinate, or behavior. Having accurate information about HPV vaccine that is 
readily available to the public during such controversies may diminish their impact.
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Introduction
Guidelines recommend human papillomavirus (HPV) vaccine for adolescents and young 
adults in the US to prevent cervical cancer and other HPV-related diseases (Markowitz et 
al., 2007; Centers for Disease Control, 2010; U.S. Food and Drug Administration, 2013). 
Despite recommendations, only 54% of adolescent females and 21% or less of adolescent 
males in the US have received at least one dose of the three-dose HPV vaccine regimen (i.e., 
vaccine initiation) (Reiter et al., 2011; Centers for Disease Control, 2012; Centers for 
Disease Control, 2013; Reiter et al., 2013). Data also suggest annual gains in HPV vaccine 
coverage among adolescent females are slowing (Moss et al., 2012), with only a 1% increase 
in vaccine initiation between 2011 and 2012. A 13% increase in vaccine initiation occurred 
among adolescent males during these same years (Centers for Disease Control, 2012; 
Centers for Disease Control, 2013). We sought to examine whether public discussion of 
vaccine concerns may be affecting beliefs and behaviors related to HPV vaccination.
Concerns about HPV vaccine have included potential short-term side effects such as pain at 
the injection site and fainting (Associated Press, 2008a; Associated Press, 2008b; Kotz, 
2008). Some parents have also expressed concerns about long-term consequences following 
HPV vaccination, such as increased sexual activity (Schuler et al., 2011; Brewer & Fazekas, 
2007; Stein, 2005) and that the vaccine may harm fertility (Katz et al., 2009). Research has 
not supported claims about lasting HPV vaccine side effects (Markowitz et al, 2007; Centers 
for Disease Control, 2010; Reiter et al., 2009; Slade et al., 2009; Forster et al., 2012). Data 
from the Vaccine Safety Datalink on adverse events following over 600,000 doses of HPV 
vaccine administered throughout the US showed no reliable increases in any of the adverse 
events examined (Gee et al., 2011). Furthermore, a recent report by the Institute of Medicine 
reported that no adverse events were “convincingly” linked to HPV vaccine; the reported 
probable mechanistic link between HPV vaccine and anaphylaxis was not supported by 
epidemiologic evidence (Institute of Medicine, 2011).
Despite unambiguous post-licensure data supporting HPV vaccine’s safety and consequent 
scientific consensus on the matter, public concern over potential side effects of the vaccine 
was heightened by a Republican presidential debate in September 2011. During this debate, 
Minnesota Representative Michele Bachmann criticized Texas Governor Rick Perry for 
issuing an executive order requiring that girls in Texas receive HPV vaccine before entering 
sixth grade. Perry stated that the order was “a mistake,” but that his decision was made in 
order to protect young women from cervical cancer (“Tea Party Republican debate”, 2011). 
Bachmann responded to Perry by stating that children “who have a negative reaction to this 
potentially dangerous drug… They don’t get a do-over” (“Tea Party Republican debate”, 
2011). The day after the debate, Bachmann again commented on HPV vaccine during a 
televised interview. Bachmann said, “I had a mother last night come up to me here in 
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Tampa, Florida, after the debate. She told me that her little daughter took that vaccine, that 
injection, and she suffered from mental retardation thereafter” (Novograd, 2011).
The comments by Bachmann and Perry and the subsequent media coverage appeared to 
cause a marked increase in interest about HPV vaccine among US residents, as measured by 
Internet searches. Indeed, the second highest volume of searches on Google for “HPV 
vaccine” occurred in September 2011 (Figure 1) (Google Trends, 2013). The only time 
period with a higher volume occurred in February 2007, soon after the vaccine first became 
available for adolescent females in the US (Markowitz et al., 2007).
Such comments may also discourage parents from getting HPV vaccine for their children. 
The health belief model posits that people’s engagement in health-related behaviors, such as 
vaccinating their children, depends on several theoretical constructs including perceived 
threat of disease and the perceived benefits and costs of taking action (e.g., vaccine efficacy 
and side effects) (Hochbaum, 1958). Parents who heard Bachmann’s comments may have 
become more concerned about the potential dangers associated with vaccinating their 
children against HPV. According to the health belief model, this would increase parents’ 
perceived barriers to HPV vaccination, which in turn would affect their HPV vaccination 
decisions. The health belief model also suggests that a “cue to action” must be present in 
order to trigger a health-related behavior. In this case, Bachmann’s comments against HPV 
vaccine may have given parents considering vaccination pause – a “cue to inaction.”
Given the large amount of attention received by the presidential candidate’s comments, it is 
important to examine the potential effects of such comments. We analyzed data from a 
national survey to determine the effects of these comments on parents’ beliefs about HPV 
vaccine and the vaccination behaviors of their adolescent sons. Although the candidate’s 
comments on HPV vaccination focused on females, the comments could have had a 
meaningful impact among parents contemplating getting HPV vaccine for their adolescent 
sons, especially as vaccination among this population is rising quickly.
Methods
Participants
The HPV Immunization in Sons (HIS) Study examined US parents’ attitudes and beliefs 
about HPV vaccination for their adolescent sons (Reiter et al., 2011; Reiter et al., 2013). 
Parents had sons ages 11–17 and belonged to an online national panel constructed by a 
survey company (Dennis, 2010). The company used a dual frame sampling approach (list-
assisted, random-digit dialing supplemented by address-based sampling) to obtain a 
probability-based sample of US households for the panel. In households without Internet 
access, the survey company provides a laptop and free Internet access to panel members for 
completing multiple online surveys every month. Panel members with their own computers 
and Internet access receive points for completing surveys that can be redeemed for small 
monetary payments. Parents received these standard incentives for participating in the HIS 
Study. We asked parents with more than one son in the eligible age range to have the son 
with the most recent birthday be the index child for the study. The Institutional Review 
Board at the University of North Carolina approved the study.
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The HIS Study was a longitudinal study, in which parents completed baseline surveys online 
in August and September 2010 (about a year prior to comments being made at the 
presidential debate) and follow-up surveys online in November 2011 (about a month after 
comments were made at the presidential debate). The survey company emailed 1,195 
parents with an invitation to complete baseline surveys. Of the 752 parents who responded, 
73% (n=547) were eligible and completed the baseline survey. For follow-up surveys, the 
company emailed invitations to 421 baseline participants who had remained part of the 
national panel. In total, 327 (78%) of these parents completed the follow-up survey. Parents 
provided consent prior to surveys, and the survey company sent three email reminders 
between baseline and follow-up to maximize participation at follow-up. We report data on 
the 327 parents who completed both baseline and follow-up surveys, as items concerning 
comments about HPV vaccination made during the presidential debate appeared on the 
follow-up survey.
Measures
Political Debate Variables—Several items on the follow-up survey examined parents’ 
familiarity with the comments made about HPV vaccine during the Republican presidential 
debate. The first item assessed awareness of these comments by asking parents, “Have you 
heard about comments on the HPV vaccine made at a recent presidential debate?” (yes or 
no). Parents who were aware received questions about their impressions of: 1) the 
candidate’s (i.e., Michelle Bachmann’s) comments about HPV vaccine; and 2) the media 
coverage that followed the debate. Response options for these two items included “mostly in 
favor of the vaccine”, “mostly against the vaccine”, and “neutral”. A final item asked 
parents how they felt the candidate’s comments had affected their opinions of HPV vaccine, 
with response options of “more in favor of the vaccine”, “more against the vaccine”, and 
“had no effect”. These items assessed whether the comments or the ensuing media coverage 
may have served as cues to action or inaction) related to HPV vaccination.
HPV Vaccination Outcomes—Parents reported whether their adolescent sons had 
received any doses of HPV vaccine (i.e., vaccine initiation). Among parents with 
unvaccinated sons, surveys assessed parents’ willingness to get their sons free HPV vaccine 
using a 5-point response scale with responses ranging from “definitely not willing” to 
“definitely willing” (coded 1–5). Surveys assessed vaccination status and willingness to 
vaccinate at both baseline and follow-up.
Surveys assessed whether parents believed HPV vaccine might cause: 1) “short-term health 
problems, like fever or discomfort” (assessed at both baseline and follow-up); 2) “lasting 
health problems for guys” (assessed at both baseline and follow-up; we will use the term 
“boys” when referring to this survey item for the remainder of this report); and 3) “lasting 
health problems for girls” (assessed only at follow-up). We added the last item to the follow-
up survey since comments made by Michelle Bachmann referenced a lasting health problem 
(i.e., mental retardation) among girls. All belief items used a 5-point response scale with 
responses ranging from “strongly disagree” to “strongly agree” (coded 1–5). Baseline and 
follow-up items used the same wording and response scales. These items addressed the 
perceived barriers construct in the health belief model.
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Demographics—The baseline survey assessed demographic characteristics (Table 1) at 
baseline for all participants. Parents described how important religion was to them using a 5-
point response scale with responses ranging from “not at all important” to “extremely 
important” (coded 1–5). Parents described their views on most political matters using a 5-
point response scale with responses ranging from “very conservative” to “very liberal” 
(coded 1–5). We defined “urban” as living in metropolitan statistical area (MSA) and “rural” 
as living outside an MSA. HIS Study surveys are available online at http://www.unc.edu/
~ntbrewer/hpv.htm.
Data Analysis
We examined whether awareness of the comments during the presidential debate was 
associated with: 1) HPV vaccine initiation among sons that occurred between baseline and 
follow-up surveys; 2) changes in parents’ willingness to get their sons free HPV vaccine 
(among parents whose sons remained unvaccinated throughout the entire study); 3) changes 
in beliefs that HPV vaccine might cause short-term health problems (among all parents); 4) 
changes in beliefs that HPV vaccine might cause lasting health problems for boys (among 
all parents); and 5) beliefs that HPV vaccine might cause lasting health problems for girls 
(among all parents). We used bivariate logistic regression to examine the association 
between awareness and HPV vaccine initiation. To examine changes in parents’ willingness 
to vaccinate and beliefs, we used a general linear model with survey time as a within-
subjects factor (2 levels: baseline and follow-up) and awareness as a between-subjects factor 
(2 levels: aware and not aware). We used bivariate linear regression to examine the 
association between awareness and the belief that HPV vaccine might cause lasting health 
problems for girls. We then generated a general linear model to examine if beliefs at follow-
up about lasting health problems differed by the gender specified in the survey items 
(within-subjects factor; 2 levels: boys and girls) and awareness (between-subjects factor; 2 
levels: aware and not aware). Analyses used SPSS version 17.0 (SPSS Inc., Chicago IL), 
and all statistical tests were two-tailed with a critical alpha of 0.05.
Results
Sample Characteristics
The majority of parents were younger than age 45 (59%), non-Hispanic white (68%), 
married or living with a partner (80%), and had attended some college (60%) (Table 1). 
About 41% of parents described themselves as “very conservative” or “somewhat 
conservative,” and 16% described themselves as “very liberal” or “somewhat liberal.” The 
remaining parents held moderate political views (41%) or refused to answer the question 
about their political views (2%). About 32% of parents identified themselves as being born-
again Christians. Parents lived in all four geographic regions of the United States, though 
largely in urban areas (84%). About 30% of parents had sons ages 11–12 at baseline, 37% 
had sons ages 13–15, and 33% had sons ages 16–17. Over half of parents (52%) also had a 
daughter between the ages of 9 and 26 (the approved age range for HPV vaccination).
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Awareness of Candidate’s Comments
Overall, 17% (57/327) of parents reported hearing about the Republican presidential 
candidate’s comments about HPV vaccine (Table 2). The majority of aware parents 
indicated that the candidate’s comments were mostly against HPV vaccine (66%, 37/56), 
though 25% believed the comments mostly favored the vaccine. In contrast, a minority of 
aware parents reported that the media coverage following the debate was mostly against the 
vaccine (21%), while 48% reported the media coverage was mostly in favor of the vaccine. 
Most parents indicated that the candidate’s comments had no effect on their opinions about 
HPV vaccine (68%). About 14% of aware parents reported that the candidate’s comments 
made them more in favor of the vaccine, while about 18% said they were more against the 
vaccine as a result of the comments.
Correlates of Awareness of Candidate’s Comments
Among parents with unvaccinated sons at baseline (n=322), 6% (20/322) indicated their 
sons received HPV vaccine by follow-up. HPV vaccine initiation did not differ between 
sons whose parents were aware of the comments made about HPV vaccine during the 
presidential debate compared to those whose parents were not aware (2% vs. 6%; odds 
ratio=0.24, 95% confidence interval=0.03–1.80, p=0.16).
Among parents whose sons remained unvaccinated for the duration of the study (n=302), 
willingness to get their sons free HPV vaccine decreased from baseline to follow-up 
(mean=3.30, SD=1.19 vs. mean=3.00, SD=1.21; p=0.001). The decrease in willingness was 
similar between parents who were aware of the comments and those who were unaware 
(F=0.53, p=0.47 interaction; Figure 2, panel A).
Among all parents (n=327), the belief that HPV vaccine might cause short-term health 
problems increased over time, from a mean of 3.27 (SD=0.58) at baseline to a mean of 3.41 
(SD=0.69) at follow-up (p<0.001). However, the increase differed between the two groups 
(F=12.83, p<0.001 interaction; Figure 2, panel B). Parents who were aware of the 
candidate’s comments showed a larger increase in belief in short-term health problems 
(mean change = 0.47; baseline mean=3.28, SD=0.62; follow-up mean=3.75, SD=0.71, 
p<0.001) compared to parents who were unaware (mean change =0.07; baseline mean=3.27, 
SD=0.57; follow-up mean=3.34, SD=0.66; p=0.14).
Belief that HPV vaccine might cause lasting health problems for boys decreased over time 
among all parents (baseline mean=3.10, SD=0.61; follow-up mean=2.92, SD=0.70; 
p=0.001). However, change in this belief did not differ by awareness (F<1 interaction; 
Figure 2, panel C). Beliefs that the vaccine might cause lasting health problems for girls 
were similar between parents who were and were not aware of the candidates’ comments 
(follow-up mean=3.04, SD=0.89; follow-up mean=2.94, SD=0.76; p=0.39). At follow-up, 
parents’ beliefs about lasting health problems for boys and girls were similar, and these 
beliefs did not differ based on awareness of the candidate’s comments (both p>0.05).
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Ample evidence has established the efficacy and safety of HPV vaccine (Markowitz et al., 
2007; Centers for Disease Control, 2010). However, comments made by public figures and 
subsequent media coverage could influence people’s beliefs and behaviors surrounding the 
vaccine. The health belief model suggests several pathways in which these comments could 
influence behaviors. For example, negative comments about HPV vaccine could decrease its 
perceived benefits and thus undermine a key motivation for vaccinating. Furthermore, the 
comments themselves may serve as cues to inaction which actually dissuade parents from 
getting their children vaccinated. The increase in public interest in HPV vaccine following 
comments made at a 2011 Republican presidential debate and in later interviews 
demonstrates the relevance of such comments. Our study documents the limited effects of 
these comments on parents’ beliefs about HPV vaccine and no effects on the vaccination 
coverage among their adolescent sons.
Fewer than one in five parents were aware of the candidate’s comments, a number that is 
surprisingly low. In public health circles, many assume the comments garnered widespread 
attention yet the evidence suggests a relatively limited impact – that is, many parents did not 
hear the comments and remained uninfluenced by them. Furthermore, parents who had and 
had not heard about the comments had similar beliefs about the long-term harms of HPV 
vaccine, willingness to vaccinate their sons, and HPV vaccine initiation among their sons. It 
is especially encouraging that awareness of the comments was not associated with lower 
vaccine initiation, given that so few adolescent males in the US have received any doses of 
HPV vaccine (Reiter et al., 2011; Centers for Disease Control, 2012; Centers for Disease 
Control, 2013; Reiter et al., 2013). Bachmann’s comments referred to HPV vaccine causing 
a lasting health problem (i.e., mental retardation), so the lack of association between parents’ 
awareness of the comments and change in beliefs about long-term harms is somewhat 
surprising.
A potential explanation for this finding is the positive media coverage that parents reported 
seeing after the debate. The Internet is one of the most common sources of information 
about HPV vaccine (Cates et al., 2010; Hughes et al., 2009; Tozzi et al., 2010), and data 
from Google confirm that online searches for HPV vaccine spiked after the debate (Figure 
1). Though information of varying quality on HPV vaccine is available online (Habel et al., 
2009), governmental agencies and academic institutions publish credible Web pages with 
high quality content about HPV vaccine (Tozzi et al., 2010). This online information may 
have increased parents’ perceived benefits of vaccination, serving to counter any increase in 
perceived barriers resulting from Bachmann’s comments.
Awareness of Bachmann’s comments was, however, associated with a larger increase in the 
belief that HPV vaccine might cause short-term health problems. Although scientific studies 
suggest that short-term side effects are no more common with HPV vaccine than other 
vaccines (Institute of Medicine, 2011), previous media attention and anecdotal accounts 
have focused on short-term side effects like pain and fainting (Kotz, 2008; Moyer, 2011). 
Previous studies indicate that though the majority of media stories are neutral toward HPV 
vaccine (Habel et al., 2009; Madden et al., 2011), many stories lack important details on 
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vaccine safety and side effects (Kelly et al., 2009; Quintero et al., 2011). The change in 
beliefs about the vaccine’s short-term harms may therefore be attributable to anecdotal 
accounts, early media stories about the vaccine’s short-term side effects (e.g., pain and 
fainting), and the media’s ongoing failure to provide more complete information about the 
vaccine’s safety. An alternative is that the candidate’s comments about long-term harms 
registered for parents aware of them, but learning more about the vaccine’s safety in the 
media coverage and online caused parents to discount or “downgrade” the severity of the 
potential harms. It is also possible that controversial comments more easily change parents’ 
beliefs about short-term than long-term harms as the former may better fit with parents’ own 
experiences of minor vaccine-associated harms like soreness. Given that comments like 
those made by the candidate may affect some parent beliefs, it is important that accurate 
information on HPV vaccine is available through a variety of channels (e.g., healthcare 
providers, the Internet, and other media sources).
Our study’s strengths included a national sample of parents and a longitudinal study design. 
Data collection for the follow-up survey closely followed the debate and subsequent media 
coverage. The HIS Study examined HPV vaccination among adolescent males, so we did 
not focus on adolescent females and their parents. Thus, the baseline survey did not include 
an item on parents’ beliefs about HPV vaccine and lasting health problems for girls, which 
would most closely reflect the content of Bachmann’s comments. However, beliefs about 
long-term harms in males and females were similar and did not differ between parents who 
had and had not heard about the candidate’s comments. Finally, HPV vaccine uptake was 
based on parents’ reports of vaccination, leaving the possibility of recall errors. HPV 
vaccination status is accurately recalled by most parents, giving us greater confidence in this 
outcome (Dorell et al., 2011).
Despite these limitations, we believe this novel study has important implications. Our 
longitudinal survey offered an opportunity to explore the impact of Michele Bachmann’s 
erroneous comments on the side effects of HPV vaccine. Though comments by public 
figures on HPV vaccine receive a great deal of attention in the media, it appears they have 
relatively little effect on parents’ beliefs and behaviors. The duration of those effects 
remains a topic for further study. Nevertheless, it is important to ensure that accurate 
information on HPV vaccine is available to parents in order to minimize the impact of such 
comments.
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Internet searches for “HPV vaccine” in the United States. Circle highlights September 2011, 
when a Republican presidential candidate made public comments about HPV vaccine. Data 
from Google Trends; 100 represents peak search volume.
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Changes in HPV vaccine willingness and beliefs over time. Error bars present standard 
errors.
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Table 1




 Female 170 (52)
 Male 157 (48)
Age (Years)
 <45 192 (59)
 45+ 135 (41)
Race / Ethnicity
 White, Non-Hispanic 221 (68)
 African American, Non-Hispanic 33 (10)
 Hispanic 59 (18)
 Other, Non-Hispanic 14 (4)
Marital Status
 Divorced, Widowed, Separated, Never Married 66 (20)
 Married or Living with Partner 261 (80)
Had Daughter Ages 9–26
 No 156 (48)
 Yes 171 (52)
Education Level
 High School Degree or Less 131 (40)
 Some College or More 196 (60)
Born-Again Christian
 No 223 (68)
 Yes 104 (32)
Importance of Religion a, mean (SD) 3.56 (1.36)
Political Affiliation b, mean (SD) 2.63 (1.00)
Son Characteristics
Age (Years)
 11–12 99 (30)
 13–15 120 (37)
 16–17 108 (33)
Household Characteristics
Household Income
 <$60,000 151 (46)
 ≥$60,000 176 (54)
Urbanicity
 Rural 51 (16)
 Urban 276 (84)
Region of Residence
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n (%)
 Northeast 65 (20)
 Midwest 86 (26)
 South 114 (35)
 West 62 (19)
Note. SD = standard deviation.
a
5-point response scale ranging from “not at all important” to “very important” (coded 1–5).
b
5-point response scale ranging from “very conservative” to “very liberal” (coded 1–5).
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Table 2
Parents’ beliefs about the presidential candidate’s comments about HPV vaccine
n (%)
Heard Candidate’s Comments about HPV Vaccine
 Yes 57/327 (17)
 No 270/327 (83)
Candidate’s Comments about HPV Vaccinea
 Mostly in Favor 14/56 (25)
 Mostly Against 37/56 (66)
 Neutral 5/56 (9)
Media Coverage about Vaccine Following Debatea
 Mostly in Favor 27/56 (48)
 Mostly Against 12/56 (21)
 Neutral 17/56 (31)
Effect of Candidate’s Comments on Opinions about HPV Vaccinea
 More in Favor 8/56 (14)
 More Against 10/56 (18)
 Had No Effect 38/56 (68)
a
Assessed among 56 parents who were aware of the candidate’s comments about HPV vaccine. One aware parent did not answer subsequent 
questions regarding these comments.
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